Literature DB >> 17224721

Clozapine-associated restless legs syndrome.

Harpreet S Duggal, Dattatreya N Mendhekar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17224721     DOI： 10.1097/JCP.0b013e31802e7587

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  8 in total

1.  Association of Restless Legs Syndrome With Incident Parkinson's Disease.

Authors:  Szabolcs Szatmari; Daniel Bereczki; Katalin Fornadi; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Miklos Z Molnar
Journal:  Sleep       Date:  2017-02-01       Impact factor: 5.849

Review 2.  Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature.

Authors:  Vijaya Kumar; Ganesan Venkatasubramanian
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-12

Review 3.  [Restless legs syndrome, periodic limb movements, and psychopharmacology].

Authors:  S Cohrs; A Rodenbeck; M Hornyak; D Kunz
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

Review 4.  Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.

Authors:  Stefan Cohrs
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  Beyond tremor and rigidity: non-motor features of Parkinson's disease.

Authors:  Matthias Löhle; Alexander Storch; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2009-08-14       Impact factor: 3.575

6.  Indian research: Focus on clozapine.

Authors:  Sandeep Grover; Alakananda Dutt; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2010-04       Impact factor: 1.759

Review 7.  Restless Legs Syndrome and the Use of Antipsychotic Medication: An Updated Literature Review.

Authors:  Wael K Saber; Ahad R Almuallim; Rami Algahtani
Journal:  Cureus       Date:  2022-08-09

8.  Restless legs syndrome: differential diagnosis and management with rotigotine.

Authors:  Giovanni Merlino; Anna Serafini; Francesca Robiony; Mariarosaria Valente; Gian Luigi Gigli
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.